Market Research Report
North America Rat Model Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||513979|
|Published||Content info||78 Pages
Delivery time: 2-3 business days
|North America Rat Model Market Forecast 2019-2027|
|Published: January 20, 2019||Content info: 78 Pages||
The North-America market is growing at a CAGR of 8.14% for the forecast period of 2019-2027 and is anticipated to generate a revenue of $XX thousand by 2027. The North-American market is expected to hold the lion's share in the rat model market by the end of the forecast period. The novel discoveries in the methodologies for monoclonal antibodies production, a growing demand for personalized medicines and the subsequent rise in demand for various rat models for research activities are some of the factors which are providing the North-American rat model market with excellent growth opportunities.
Various aspects like new and improved genome editing techniques, increasing research by biotechnological and biopharmaceutical companies and ease of access for the transgenic rat methodologies are acting as the major drivers for the market. The rat model market segmentation depends on various factors such as the type of rat models (inbred, knock-out, hybrid, outbred, etc.), the type of components; which includes the technology used, the service provided and the various rat care products needed during the research, and also on the basis of the application of the models in various medical and research fields. The United States has shown the highest growth in the North American region and is expected to continue its dominance over the forecasted period.
Because of the presence of major pharmaceutical companies like Roche, Merck & Co., and Novartis in the North American region and their main focus being on pre-clinical trials and clinical research studies, the demand for the rat models have increased considerably in the US. Also, Lab Corp is another such company in the North American market which is now primarily focusing on genomic study. The other companies currently leading the North American rat model market scene are Janvier Labs, Taconic Biosciences, Transposagen Biopharmaceuticals Inc., Charles River Laboratories Inc., Oncodesign S.A., Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Cyagen Biosciences Inc., Clea Japan, Transviragen Inc., Envigo, Hera Biolabs Inc., Genoway S.A., Vivo Biotech Ltd., Laboratory Corporation of America Holdings and Biomere.